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Background: Dual oxidase maturation factor 1 (DUOXA1) has been associated with the maturation of the reactive
oxygen species (ROS) producing enzyme, dual oxidase 1 (DUOX1) in the adult thyroid. However, ROS have also
been implicated in the development of several tissues. We found that activated muscle satellite cells and primary
myoblasts isolated from mice express robust levels of DUOXA1 and that its levels are altered as cells differentiate.
Results: To determine whether DUOXA1 levels affect muscle differentiation, we used an adenoviral construct
(pCMV5-DUOXA1-GFP) to drive constitutive overexpression of this protein in primary myoblasts. High levels of
DUOXA1 throughout myogenesis resulted in enhanced H2O2 production, fusion defects, reduced expression of
early (myogenin) and late (myosin heavy chain) markers of differentiation, and elevated levels of apoptosis
compared to control cells infected with an empty adenoviral vector (pCMV5-GFP). DUOXA1 knockdown (using a
DUOXA1 shRNA construct) resulted in enhanced differentiation compared to cells subjected to a control shRNA,
and subjecting DUOXA1 overexpressing cells to siRNAs targeting DUOX1 or apoptosis signal-regulating kinase 1
(ASK1) rescued the phenotype.
Conclusions: This study represents the first to demonstrate the importance of DUOXA1 in skeletal muscle
myoblasts and that DUOXA1 overexpression in muscle stem cells induces apoptosis and inhibits differentiation
through DUOX1 and ASK1.
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The process of myogenesis is often studied using acti-
vated satellite cells. These muscle stem cells, located be-
tween the plasma membrane and the basal lamina, form
the basis for effective muscle regeneration [1]. Under
appropriate stimuli, these normally quiescent cells enter
back into the cell cycle, and undergo several rounds
of proliferation. Myoblast progression towards mature
muscle is initiated by permanent cell cycle exit. These
cells, now called myocytes, line up and fuse with neigh-
boring cells to produce a single-membrane structure* Correspondence: sdsandiford@gmail.com; sli@uwo.ca
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reproduction in any medium, provided the orhousing potentially hundreds of nuclei. The process of
myogenesis is dependent upon the expression of the
Myogenic Regulatory Fators (MRFs) that include Myf5,
MyoD, myogenin and MRF4 [2]. Both MyoD and Myf5
are expressed in proliferative myoblasts and Myf5 is
downregulated as cells progress through myogenesis.
Once the cells exit the cell cycle, myogenin and MRF4
are expressed. MRF4 can also act upstream of Myf5 and
MyoD [3].
Although there appears to be a certain degree of re-
dundancy between the MRFs, data from knockout stud-
ies suggest unique roles for these transcription factors.
The majority of myoblasts follow this rather predictable
pattern of myogenesis and, in mature muscle, most of
the nuclei are terminally differentiated. However, theral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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percentage of cells that escape differentiation, maintain
Pax7 expression, downregulate MyoD, and return to
quiescence [4]. These Pax7+/MyoD- cells are thought
to maintain a small pool of muscle stem cells, from
which future proliferative myoblasts may be derived.
Cells that escape differentiation and that fail to return to
quiescence undergo apoptosis [5,6]. Indeed, apoptosis is
normally regarded as a natural part of differentiation,
and identifying factors involved in cell cycle control and
survival undoubtedly play an important role in our gen-
eral understanding of myogenesis and in the etiology of
many muscle degenerative diseases.
Previously, our lab characterized a protein termed
Numb Interacting Protein (NIP), an interactor of the cell
fate determinant, Numb, in Drosophila Melanogastor
[7]. Mammals have two isoforms of NIP (NIP1 and
NIP2), but the role of mammalian NIP genes in Numb
function has not been demonstrated. Subsequently,
others identified NIP1 and NIP2 as genes arranged in
head-to-head orientation with dual oxidases (DUOX1
and DUOX2) [8]. Specifically, the protein products of
these genes, renamed DUOXA1 and DUOXA2 respect-
ively, were shown to be important for the maturation of
DUOX1 and DUOX2 and, ultimately, the production of
H2O2 and thyroid hormone. Dual oxidases belong to the
nicotinamide adenine dinucleotide phosphate (NADPH)
oxidase (Nox) family of enzymes responsible for the
generation of reactive oxygen species (ROS) in a variety
of cell types [9-12]. The family is made up of Nox1
through Nox5 and DUOX1 and DUOX2. While some
family members require additional subunits (p47phox
and p67phox) for proper function, DUOX1 and DUOX2
have no such requirement [13,14]. Instead, these two
Ca2+-dependent Nox members rely on DUOXA1 and
DUOXA2 for their maturation and/or translocation to
the plasma membrane for their activation. Research
has demonstrated that DUOXA1 and DUOXA2 form
heterodimeric complexes with their respective dual
oxidases [15,16] and, in their absence, DUOX enzymes
remain internalized in the endoplasmic reticulum
and H2O2 is not produced. Interestingly, relatively
few adult tissues have been demonstrated to express
DUOXA1. Grasberger and Refetoff [8] confirmed high
levels of this protein in a limited number of tissues in-
cluding the thyroid, lung and salivary glands. Indeed,
most of the studies on DUOXA1 and DUOXA2 revolve
around their function in the thyroid and hormone bio-
synthesis and, not surprisingly, natural mutations in
the DUOXA2 gene have been linked to hypothyroidism
[17,18]. However, the presence of DUOX and DUOXA
in primitive organisms (lacking a thyroid gland),
suggests roles that extend beyond thyroid hormone
biosynthesis [19]. Others have suggested that DUOX1in lung epithelia may play a role in host defence [20],
and silencing of DUOX1, DUOX2 and their respective
maturation factors has been demonstrated in lung can-
cer cells [21]. Since 2006, DUOXA1 has been studied
extensively as a mediator of DUOX1 activity. However,
studies into the potential roles for DUOXA1 in other
tissues and during development are lacking.
We have determined that DUOXA1 mRNA levels are
altered throughout embryogenesis and that levels are el-
evated as early as embryonic (E) day seven (E7) in the
developing mouse [22]. The early expression pattern of
DUOXA1 (before the development of many organs) sug-
gests that it may play important roles in embryogenesis.
Here we report, for the first time, that DUOXA1 (and its
corresponding dual oxidase, DUOX1) is expressed in
murine muscle satellite cells and throughout myogen-
esis. Overexpression of DUOXA1 is associated with ele-
vated levels of H2O2 and inhibition of differentiation
through increased apoptosis in a DUOX1-dependent
manner. We further show that a common regulator of
apoptosis, apoptosis signal-regulating kinase 1 (ASK1), is
a downstream target of DUOXA1-mediated H2O2 pro-
duction, and that knockdown of either DUOX1 or ASK1
rescues the DUOXA1 overexpression phenotype.Results
Newly activated satellite cells and primary myoblasts
express DUOXA1
To determine whether muscle satellite cells express
DUOXA1, myofibre cultures derived from mouse ex-
tensor digitorum muscle were examined by immuno-
fluorescent microscopy. Robust DUOXA1 expression
was detected at 24 hrs of culture in cells that had
entered back into the cell cycle (as demonstrated
by positive BrdU staining (Figure 1A). In order to
characterize the function of DUOXA1, we generated
an anti-DUOXA1 antibody against the C-terminal
portion of the mouse DUOXA1 protein. The specificity
of the antibody was verified by overexpressing full
length DUOXA1 in 293T cells, and by immunostaining
performed on primary myoblasts in the absence or
presence of the antigenic peptide (Additional file 1:
Figure S1A-D). The antibody was also verified using
the immortalized C2C12 myoblast cell line (Additional
file 1: Figure S1E).
We were also interested in knowing whether DUOXA1
expression was maintained in primary myoblasts that had
migrated from the parent fibre. Primary myoblasts were
derived from myofibre cultures, and culture purity was
determined to be > 95% using the myoblast marker, desmin
(data not shown). Immunostaining performed on prolifera-
tive myoblast (MB) and differentiated myotube (MT) sam-











































Figure 1 (See legend on next page.)
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Figure 1 Newly activated satellite cells and primary myoblasts express DUOXA1. (A) Scheme of myogenesis indicating common markers
for precursor cells (Pax7), myoblast commitment (Myf5, MyoD), early differentiation (myogenin) and late differentiation (Myosin heavy chain - MyHC).
Myofibres were isolated and incubated with 10 μM bromodeoxyuridine (BrdU). Samples were cultured for 24 hours, upon which time they
were harvested, fixed in 2% paraformaldehyde, and immunostained for DUOXA1 (green) and BrdU (red). Results show evidence of activated
DUOXA1+/BrdU+ satellite cells. Scale bar: 20 μm. (B) Myofibre and primary myoblast cultures obtained from the extensor digitorum longus
muscles of adult mice demonstrate DUOXA1 expression in newly-activated satellite cells, primary myoblasts and differentiated myotubes.
Primary myoblasts which have migrated away from the parent fibre also show extensive cytoplasmic and nuclear staining of DUOXA1 (green)
in cells that co-express DUOX1 (red). The nuclei of differentiated myotubes are generally devoid of DUOXA1. White arrows indicate alterations
in the localization of DUOXA1 in single cells compared to that in fused myotubes. Counterstaining with DAPI is provided as a nuclear marker.
Scale bars: 50 μm. Inset scale bars: 20 μm. (C) The expression of DUOXA1 and DUOX1 (along with Myf5, MyoD, myogenin & MyHC) in myoblast (MB)
and myotube (MT) samples was analyzed by quantitative reverse transcription (qRT)-PCR. The levels of mRNA were normalized to GAPDH and presented as
values relative to expression at day 0 (d0). (D) DUOXA1 levels in MB and myocyte samples (MC - which had not undergone fusion) were also analyzed by
flow cytometry. The normal arrow and broken arrow heads in MC samples indicate populations of cells that have either downregulated or upregulated
DUOXA1 expression respectively. (E) Markers of myogenesis were also analyzed by Western blot. * Significantly different from d0 (P < 0.05). mRNA R.L.
indicates mRNA relative level.
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plasm of fused myotubes (Figure 1B).
Dynamic DUOXA1 expression during myogenesis
We next examined the temporal expression pattern of
DUOXA1 as cells undergo differentiation. Proliferative
primary myoblasts were either maintained in growth
medium (GM), or allowed to differentiate for four days
in differentiation medium (DM). Quantitative reverse
transcription (qRT)-PCR suggests that DUOXA1 mRNA
levels are altered as cells differentiate (Figure 1C and E).
Due to differences in DUOXA1 localization between
proliferating and differentiating cells, we decided to use
flow cytometry as a means of further characterization.
Flow cytometry performed on proliferative MB and on
differentiating myocytes (MC – harvested before the
process of fusion) suggests that separate populations of
DUOXA1 emerge (Figure 1D). Taken together, these re-
sults suggest that DUOXA1 is a highly dynamic protein
whose levels and localization depend on whether sam-
ples are dividing or differentiating.
DUOXA1 overexpression inhibits myogenesis
In order to determine whether altering the levels of
DUOXA1 might have an impact on myogenesis, we cre-
ated an adenoviral vector containing full-length mouse
DUOXA1 (pCMV5-DUOXA1-GFP). Virus containing
the empty vector (pCMV5-GFP) was used as the
corresponding control. Cells were infected, and induced
to differentiate 24 hrs later (designated as day 0). The ef-
ficiency of adenoviral infection in primary myoblasts was
calculated to be 70-80% (data not shown). Quantitative
RT-PCR at day 1 suggests that DUOXA1 overexpression
reduced markers of early (myogenin) and late (myosin
heavy chain – MyHC) differentiation by 66.4% and
69.1%, respectively (P < 0.05, Figure 2A). Similarly, MyoD
mRNA was also reduced by 49.5% in cells overexpress-
ing DUOXA1 (P < 0.05, Figure 2A). Confocal immuno-
fluorescence was performed on samples harvested at day2 of differentiation. Although the numbers of MyoD+(red)/
GFP+(green) cells were not significantly different between
samples (Figure 2B, C and H), there was a 48.4% reduction
in the number of myogenin+(red)/GFP+(green) cells in
DUOXA1 overexpressing samples compared to GFP cells
(P < 0.05, Figure 2D, E and H). Similarly, immunostaining
with an antibody against MyHC revealed a 29.8% decrease
in the number of MyHC+(red)/GFP+(green) cells infected
with DUOXA1, compared to GFP control samples (P <
0.05, Figure 2F, G and H). The ability of cells to fuse was
also hindered in DUOXA1 overexpressing cells (P < 0.05,
Figure 2I).
DUOXA1 overexpression results in an increase in
H2O2 production
It has previously been determined that the transloca-
tion and maturation of DUOX1, and the subsequent
production of H2O2, is dependent on the expression
of DUOXA1 [8]. Having established the effects of
DUOXA1 overexpression on myogenic differentiation,
we questioned whether overexpression also resulted in
alterations in the production of H2O2. Previous reports
of DUOX1 expression in myoblasts had not been dem-
onstrated, but we determined by immunostaining that
DUOX1 was located primarily at the plasma mem-
brane in these cells. We utilized an amplex red reagent
to establish that DUOXA1 overexpressing cells indeed
released more H2O2 into the surrounding medium
than did GFP control cells. Overexpression resulted in
a 59.3% increase in the levels of H2O2 (P < 0.05,
Figure 2J). Hence, DUOXA1 overexpression resulted in
elevated levels of H2O2, compromised fusion and
inhibited differentiation.
DUOXA1 overexpression elevates apoptosis signal-
regulating kinase (ASK) 1 expression and induces apoptosis
in primary myoblasts undergoing differentiation
Within 48 hours of differentiation, DUOXA1 overexpress-


















































Figure 2 DUOXA1 overexpression in primary myoblasts inhibits differentiation. Primary myoblasts were infected with adenoviral vectors
containing pCMV5-GFP (GFP), or pCMV5-DUOXA1-GFP (GFP-DUOXA1). (A) Cells were subjected to adenoviral constructs and, 24 hours later,
growth medium (GM) was replaced with differentiation medium (DM - designated as day 0). mRNA was harvested 24 hours after the initiation of
differentiation (day 1). Quantitative RT-PCR was performed on representative samples from DUOXA1 overexpressing cells and GFP controls. Data
was normalized to GAPDH and GFP-DUOXA1 values are presented relative to GFP control cells. MyoD, myogenin and MyHC mRNA levels are all
significantly reduced in samples overexpressing DUOXA1. (B-H) Immunostaining on samples harvested on day 2 suggests the number of
GFP+/myogenin+ and GFP+/MyHC+ cells are clearly reduced in DUOXA1 overexpressing cells (E, G, H) compared to GFP controls (D, F, H).
Numbers of GFP+/MyoD+ cells are not different between samples (B, C, H). Counterstaining with DAPI is provided as a nuclear marker. Scale bars:
100 μm. (H) Graphical representation of the data shown in B-G. GFP-DUOXA1 counts are represented relative to GFP controls. (I) The ability of
cells overexpressing DUOXA1 to fuse is also impaired compared to GFP control cells collected at day 2. (J) In order to assess the amount of H2O2
released from the cells, the amplex red reagent was used to demonstrate that DUOXA1 overexpression results in significant increases in H2O2 in
the culture medium. Levels of H2O2 were corrected using cell counts and the amount of H2O2 in DUOXA1 overexpressing cells are expressed
relative to GFP controls. Values represent means from myoblasts isolated from 3–5 mice ± SE. * Significantly different from GFP control (P < 0.05).
Sandiford et al. Cell Communication and Signaling 2014, 12:5 Page 5 of 15
http://www.biosignaling.com/content/12/1/5whether overexpression resulted in enhanced apoptosis
during differentiation. We used AnnexinV-Cy3 and
propridium iodide (TOPRO-3) to determine that, by
day 1 of differentiation, DUOXA1 overexpression re-
sulted in more than double the number of Annexin
positive cells and over ten times the number of
TOPRO-3 positive cells compared to GFP controls(P < 0.05, Figure 3A and B), indicating significant
increases in the number of cells undergoing ear-
ly (Annexin positive) and late (Annexin, TOPRO-3
double positive) apoptosis. We next sought to deter-
mine whether enhanced apoptosis was associated with
elevated levels of ASK1, a common mediator of apop-

























Figure 3 DUOXA1 overexpression elevates apoptosis signal-regulating kinase (ASK) 1 levels and induces apoptosis. (A-B) Cells were
infected with pCMV5-GFP (GFP), or pCMV5-DUOXA1-GFP (GFP-DUOXA1). Twenty-four hours after infection, growth medium was replaced with
differentiation medium and cells were harvested 24 hr later (day 1). (A) Apoptosis was measured by labelling samples with Annexin V-Cy3 (red) and
propridium iodide (TOPRO-3 - magenta). Cells overexpressing DUOXA1 undergo massive amounts of apoptosis, as evidenced by cells undergoing early
(Annexin V+/TOPRO-3-) and late (Annexin V+/TOPRO-3+) apoptosis. Scale bars: 100 μm. (B) Graphical representation of data presented in (A). Counterstaining
with DAPI is provided as a nuclear marker. (C) Levels of ASK1 in GFP and GFP-DUOXA1 samples were analyzed by qRT-PCR. Samples were normalized to GAPDH
and GFP-DUOXA1 values are displayed relative to GFP controls. Data suggest upregulation of ASK1 in samples overexpressing DUOXA1. * Significantly different
from GFP control (P < 0.05).
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of ASK1 mRNA by five hours post infection (P < 0.05,
Figure 3C).
DUOXA1 knockdown results in enhanced differentiation
In order to further characterize a role for DUOXA1 in
myogenesis, we used shRNA constructs targeting two
separate regions of the DUOXA1 gene (DUOXA1
shRNA). A construct targeting luciferase was used as the
corresponding control (CON shRNA). Data from one
shRNA construct is depicted in Figure 4. DNA was in-
troduced into the cells by nucleofection and, 24 hrs later,
GM was replaced by DM. Samples were harvested on
day 2. We demonstrated that DUOXA1 knockdown re-
duced DUOXA1 mRNA and protein using qRT-PCR,
immunofluorescence and flow cytometry (Figure 4A and
B). The amount of H2O2 released from the cells was also
reduced by 31% (P < 0.05, Figure 4C). Quantitative RT-
PCR demonstrated that, while MyoD and MyHC were
not differentially altered by DUOXA1 knockdown, there
was a 58.7% increase in myogenin mRNA (P < 0.05,
Figure 4D). Similarly, the number of Myogenin+ cellswas increased upon DUOXA1 knockdown (P < 0.05,
Figure 4E-G). The number of MyoD+ cells was not
different between groups. Additionally, DUOXA1 knock-
down resulted in a 91% increase in fusion (P < 0.05,
Figure 4H), and led to a 45% decrease in the number of
cells undergoing apoptosis, as measured by AnnexinV
staining (P < 0.05, Figure 4I). Taken together, these data
suggest that DUOXA1 knockdown reduces the levels of
H2O2, enhances early markers of differentiation and the
ability of cells to fuse.
The phenotype associated with DUOXA1 overexpression
can be alleviated by DUOX1 or ASK1 depletion
The association between DUOXA1 and DUOX1 in other
cell types is well established [8,15,16,22]. In order to deter-
mine whether the DUOXA1 phenotype was DUOX1 and/
or ASK1-dependent, we subjected primary myoblasts to
siRNAs targeting DUOX1, ASK1 or a scrambled control by
nucleofection. Twenty-four hours after nucleofection, sam-
ples were infected with adenoviral constructs containing
GFP-DUOXA1 or a GFP control and, 24 hours later, differ-















































Figure 4 (See legend on next page.)
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Figure 4 DUOXA1 knockdown decreases H2O2 production and enhances differentiation. Primary myoblasts were subjected to
nucleofection using shRNA constructs targeting DUOXA1 (DUOXA1 shRNA) or luciferase (CON shRNA). Twenty-four hours later, growth medium
was replaced with differentiation medium, and samples were harvested 48 hours after the initiation of differentiation (day 2). (A) Quantitative
RT-PCR was performed on representative samples subjected to DUOXA1 shRNA and CON shRNA. Data was normalized to GAPDH and DUOXA1
shRNA values are presented relative to CON shRNA cells. (B) Confocal immunofluorescence and flow cytometry were used to demonstrate the
ability of the DUOXA1 shRNA constructs to reduce DUOXA1 protein levels. Scale bars: 20 μm. (C) Amplex red was used to illustrate that DUOXA1
knockdown reduces the amount of H2O2 released by the cells. Levels of H2O2 were corrected using cell counts, and the amount of H2O2 produced by
DUOXA1 shRNA cells are expressed relative to CON shRNA samples. (D) Quantitative RT-PCR was used to confirm significantly higher levels of myogenin,
but not MyoD or MyHC, in DUOXA1 shRNA samples. (E-G) Immunostaining on differentiating samples suggests that the number of Myogenin+ cells is
higher in DUOXA1 shRNA (E) samples than in controls (F). Scale bars: 200 μm. (G) Graphical representation of some of the data in E & F. The number of
MyoD+ cells was not different between groups. (H) At day 2, enhanced fusion was associated with DUOXA1 knockdown. (I) Annexin staining on
samples subjected to DUOXA1 shRNA or CON shRNA suggest that DUOXA1 knockdown results in significantly reduced apoptosis. Values represent
means for myoblasts isolated from 3–5 mice SE. * Significantly different from CON shRNA (P < 0.05).
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control siRNA and DUOXA1 overexpression demonstrated
an 18.8% decrease in myogenin mRNA and a 37.9%
decrease in MyHC mRNA compared to control cells
(P < 0.05, Figure 5A). Reductions in these two markers were
alleviated by either DUOX1 knockdown or ASK1 knock-
down. We used confocal microscopy and cell counts to
determine that scrambled control siRNA cells overexpress-
ing DUOXA1 experienced a 49.9% reduction in fusion
(P < 0.05) which was reversed with either DUOX1 siRNA
or ASK1 siRNA (Figure 5B and C). Similarly, the 43.8% re-
duction in MyHC witnessed with DUOXA1 overexpression
(P < 0.05) was also alleviated upon knockdown of DUOX1
or ASK1 (Figure 5C). Levels of apoptosis common to
DUOXA1 overexpression were also significantly lowered
when these cells were subjected to DUOX1 or ASK1 deple-
tion (P < 0.05, Figure 5C). Although there was a similar
trend for myogenin, levels of this marker were not signifi-
cant. In order to determine whether DUOX1 and/or ASK1
knockdown altered the ability of the cells to differentiate,
we subjected samples to either DUOX1 siRNA or ASK1
siRNA and CON siRNA. We determined that ASK1 knock-
down on its own had no effect on differentiation, while
DUOX1 knockdown increased the ability of the cells to
fuse, but had no effect on the expression of Myogenin or
MyHC (Figure 5D-F). Based on these findings, we propose
a model whereby DUOXA1 overexpression hinders differ-
entiation and initiates apoptosis through mechanisms in-
volving DUOX1 and ASK1 (Figure 6).
Discussion
This report represents the first study to demonstrate the
presence of a DUOX1-DUOXA1 system in activated sat-
ellite cells and primary myoblasts, and suggests an im-
portant role for DUOXA1 in normal myoblast function
and differentiation. Our data imply that DUOXA1 levels
and localization are altered as myoblasts differentiate,
and that overexpression results in increased H2O2 pro-
duction, apoptosis and defective differentiation. In agree-
ment with our previous findings [22], we demonstratethat overexpression of DUOXA1 (and not the dual oxi-
dase itself ) can enhance H2O2 production in cells that
already express DUOX1. The observation that endogen-
ous DUOXA1 levels and localization change as cells dif-
ferentiate is an interesting one. Flow cytometry data
suggests that differentiation stimulates the emergence of
two populations of cells with respect to DUOXA1 levels.
The significance of these separate populations remains
unclear. This pattern has been identified in other types
of differentiating cells (data not shown) and suggests a
level of caution be applied when analyzing DUOXA1
levels solely by Western blot.
The observation that adult skeletal muscle produces
low amounts of ROS under resting conditions is well
established, as is the importance of ROS in force
development [23] and during myocyte disruption [24].
However, a potential role for endogenous ROS in myo-
genesis is poorly understood. Reactive oxygen species
(ROS) are known to be important for the differentiation
of cardiac [25-29], smooth muscle [30,31] and neuronal
cells [22,32,33]. In skeletal muscle, it has been demon-
strated that differentiation is naturally associated with
elevated levels of ROS [34,35] and, similar to other tis-
sues, there are reports suggesting that a rise in ROS is
necessary to support differentiation and fusion [34-36].
Nox family members Nox1, Nox2 and Nox4 have been
described in skeletal muscle and in myoblasts [19,35].
The ability of Nox proteins to mediate differentiation
appears to be linked to ROS production, and the emer-
ging picture is that proper control of development is
tightly linked to ROS levels. Piao et al. [35] used siRNA
against Nox1 and Nox2, and a range of inhibitors to de-
termine that both knockdown of Nox2 and the use of
ROS scavengers inhibit myogenesis. Even though alter-
ations in myoblast DUOXA1 levels produce an opposite
phenotype to that observed for Nox2, it is interesting to
note that the characterization of DUOXA1 and DUOX1
in myoblasts represents the fourth Nox system to be de-
scribed in these cells. Differences in temporal expression












































































Figure 5 (See legend on next page.)
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Figure 5 DUOXA1 inhibits myogenesis through a mechanism involving DUOX1 and ASK1. Small interfering RNAs targeting DUOX1
(DUOX1 siRNA), ASK1 (ASK1 siRNA) or a scrambled control (CON siRNA) were introduced into myoblasts using nucleofection. After 24 hrs, samples
were subjected to adenoviral vectors containing GFP-DUOXA1 (DUOXA1) or GFP. (A) Quantitative RT-PCR was performed on samples harvested
on day 1. Data was normalized to GAPDH and DUOXA1 values are presented relative to corresponding GFP controls. Reductions in the levels of
myogenin and MyHC mRNA associated with DUOXA1 overexpression are alleviated upon knockdown of DUOX1 or ASK1. (B) Images demonstrating
the ability of ASK1 siRNA to rescue the DUOXA1 phenotype. GFP is visualized in samples. Scale bars: 500 μm. (C) Graphical representation of cell
counts. Confocal immunofluorescence was performed on samples harvested at day 1, and the number of cells expressing Myogenin and MyHC
were counted. The number of MyHC+ cells was reduced in samples subjected to CON siRNA and DUOXA1 overexperssion compared to CON
siRNA and GFP controls. This was alleviated by ASK1 knockdown. Counts are represented relative to their corresponding controls (e.g. DUOX1si-
DUOXA1 relative to DUOX1si-GFP). The large number of Annexin-V+ cells witnessed upon DUOXA1 overexpression and defects in cell fusion can
be reversed with siRNAs targeting DUOX1 and/or ASK1. (D-F) To determine whether DUOX1 or ASK1 knockdown alone would have an effect on
differentiation, we subjected samples to DUOX1 siRNA or ASK1 siRNA and a suitable control (CON siRNA). DUOX1 knockdown enhances fusion
(D), but not Myogenin or MyHC mRNA (E) or protein levels (F). ASK1 knockdown had no effect on differentiation. *Significantly different from
samples infected with the corresponding GFP control (P < 0.05. # Significantly different from samples nucleofected with a scrambled control
(CON siRNA) and infected with a DUOXA1 construct (CONsi-DUOXA1, P < 0.05).
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enzymes may be activated by different stimuli, that they
may signal through different pathways, and that they are
likely not fully redundant.
It should also be noted that the immortalized C2C12
myoblast cell line is the model of choice in many investi-
gations. Work in our lab suggests that C2C12 cells may
be considerably more resistant to elevations in ROS
levels than are primary myoblasts. Others have reported
using mM levels of H2O2 to disrupt myogenesis. Although
the exact level of H2O2 needed to induce catastrophic
damage remains unclear, investigations confirming links be-
tween ROS and apoptosis in C2C12 cells typically useFigure 6 A model for the effects of DUOXA1 on muscle differentiatio
downstream of MyoD to initiate massive cell death and impair differentiati
to siRNAs targeting DUOX1 or ASK1 rescues the overexpression phenotype
presented in green and red, respectively, and suggest that DUOXA1-media
DUOX1 and ASK1.0.5 mM to 4 mM H2O2 [37-39]. Our preliminary data
suggest that myogenesis can be inhibited using as little as
1–10 μM H2O2 in primary myoblasts (S.D.E.S, unpublished
data), with the ability of the cells to fuse being particularly
susceptible. We thus decided to focus our studies on
primary myoblasts since we assumed the data would be
more relevant than that derived from immortalized cells.
However, one of the challenges of working with primary
cells is the small sample sizes. Since many of the conditions
applied in this study also resulted in cell death, we made
the decision to focus primarily on cell counts, qRT-PCR
and, where applicable, flow cytometry. Immunoblotting
was not possible under these conditions. However, the datan. The proposed model suggests that elevated levels of DUOXA1 act
on. DUOXA1 knockdown enhances differentiation. Samples subjected
. The effects of DUOXA1 overexpression and knockdown/rescue are
ted apoptosis inhibits differentiation through a mechanism involving
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mental to myogenesis and that its levels need to be strictly
controlled. Future studies incorporating mouse and human
primary cell models should begin to provide a clearer pic-
ture of the overall sensitivity of myoblasts to ROS and to
provide a better understanding of how the Nox family of
enzymes work to promote and inhibit myogenesis.
Proper skeletal muscle differentiation is dependent
upon adequate pools of fusion-competent myoblasts.
Apoptosis naturally occurs during differentiation, and
there is some evidence to suggest that mediators of cell
death are, in fact, required to initiate differentiation
[6,40]. However, there appears to be some discrepancy
between appropriate (and expected) levels of death
associated with normal differentiation, and exaggerated
levels of apoptosis resulting in severe reductions in cell
numbers and hindered development. There are several
reports indicating that controlling the level of apop-
tosis that occurs during differentiation may be thera-
peutically useful for a variety of degenerative diseases
and aging [41-46].
Our results indicate that DUOXA1 overexpression can
initiate the process of apoptosis through DUOX1 and
ASK1. In our rescue experiments, DUOXA1 overexpres-
sion resulted in decreases in Myogenin mRNA but not
protein. In other experiments (where levels of mRNA
protein coincide with each other) cells were harvested
after two days of differentiation. In our rescue experi-
ments, samples were harvested after a single day of
differentiation. This is due to the fact that the primary
cells had been subjected to both adenovirus and nucleo-
fection. Nucleofection is a very efficient method of gene
transfer in primary myoblasts, but it also results in a
small amount of toxicity. Since detectable differences in
mRNA will always precede alterations in the level of
protein, this earlier time point may have compromised
our ability to detect larger differences in some of our
parameters.
We discovered that ASK1 knockdown had no effect on
differentiation. However, the observation that DUOX1
knockdown enhances the ability of the cells to fuse
coincides with DUOXA1 data. It is curious that DUOX1
knockdown was not as effective as DUOXA1 at altering
levels of Myogenin protein or RNA levels. While our data
still suggests a connection between DUOXA1 and DUOX1
in the production of ROS and cell death in primary
myoblasts, it is possible that DUOXA1 also has some
DUOX1-independent role(s) that might also induce ROS
production and/or cell death.
There are few papers focused on the effects of ASK1
on myogenesis. We chose this target since ASK1 has
been previously shown to be activated by oxidative stress
and it is known to lie upstream of both the JNK and p38
MAPK apoptotic pathways [47]. It was felt that thistarget would give us the most information, and serve as
a starting point for future studies between DUOXA1
and apoptosis. A recent investigation by Han and co-
workers [48] suggests that, apart from initiating cell
death, p38 MAPK and JNK activation enhance myostatin
expression. Myostatin is a negative regulator of skeletal
muscle mass [49,50]. Since ASK1 lies upstream of both
p38 MAPK and JNK, it follows that its stimulation might
enhance myostatin expression and result in decreased
myocyte fusion. Clear links between H2O2 and myostatin
expression remain to be established, but a recent investi-
gation determined that C2C12 cells treated with myosta-
tin produced higher levels of ROS than did controls
[51]. Future studies might better determine the link
between ROS, ASK1, myostatin and myogenesis.
Similarly, notch genes are also implicated in differenti-
ation. Originally, our lab characterized DUOXA1 as a
Numb-interacting protein. Drosophila NIP (dNIP) was
observed to anchor Numb as a crescent to one side of
the plasma membrane shortly before cell division, thus
ensuring daughter cells to inherit different amounts of
Numb and acquire distinct cell fates [7]. In an attempt
to address the biological function of dNIP, we gen-
erated fly lines with either maternal deletion of nip or
those expressing a UAS-nip-RNAi transgene. While nip
deletion led to growth arrest and death at the 1st larval
instar, NIP-knockdown flies survived to adulthood.
However, these flies exhibited defects in pre-adult devel-
opment, displayed an inability to handle oxidative stress,
and had a significantly reduced life span [52]. Intri-
guingly, these phenotypes could be fully rescued by
ubiquitous expression of a UAS-nip or a UAS-nipNN/AA,
the latter producing a NIP mutant bearing double Asn
to Ala mutations, shown to be defective in Numb bind-
ing [7,52]. These results suggest that dNIP is essential
for Drosophila development, but its in vivo function may
not be related to Numb binding. We have also recently
determined that mammalian DUOXA1 and Numb show
differences in expression patterns in the developing
brain, and that overexpression of DUOXA1 in P19 cells
does not affect the regulation of Numb [22]. Thus, based
on our recent findings in Drosophila, mouse brain
and P19 cells, it is unlikely that interactions between
DUOXA1 and Numb are functionally relevant.
Conclusion
This is the first report of DUOXA1 in satellite cells and
primary myoblasts, and the results of our work suggest
this protein (as has been demonstrated in the thyroid
and lung) is partially responsible for ROS production in
developing muscle and that tight control of its levels is
necessary for optimal myogenesis. Despite the presence
of DUOXA1 and DUOX1 in these cells throughout
muscle development, our work suggests that their levels
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our work demonstrates that constitutive overexpression
of DUOXA1 induces apoptosis and inhibits differenti-
ation through mechanisms involving DUOX1 and ASK1.
However, it remains possible that DUOX1-independent
mechanisms also contributed to the phenotype associ-
ated with overexpression. DUOXA1 is localized in both
the cytoplasm and nucleus in dividing myoblasts, while
DUOX1 appears to be restricted to the plasma mem-
brane. This result is consistent with previous observa-
tions in which DUOXA1 is associated with internal
membranes, but remains crucial for the maturation and/
or translocation of DUOX1 to the periphery of the cell
[8]. The nuclear presence of DUOXA1 remains curious
given its five transmembrane domains and well-
documented association with DUOX1. Our lab has re-
cently performed extensive mass spectrometry analysis
to identify alternate binding partners for DUOXA1 in
both the cytoplasm and nucleus [22]. Future investiga-
tions might seek to determine whether this protein has
DUOX1-independent roles and whether it might be
upregulated in diseased or aging muscle to determine
its potential value as a therapeutic agent.
Materials and methods
Myofibre isolation and cell culture
Adult CD57/BL6 mice (> 6 weeks of age) were used for
myofibre and primary myoblast isolations. Mice were
housed and bred in the Health Sciences Animal Care
Facility at the University of Western Ontario, and all
procedures were monitored under a protocol approved
by the University of Western Ontario Council on
Animal Care. Mice were killed by cervical dislocation
and myofibres were isolated as previously described [53].
Briefly, extensor digitorum longus (EDL) muscles were
dissected from the hindlimbs and digested in collagenase
D (Roche Applied Science, Mississauga, ON, Canada)
for one hour at 37°C. Individual fibres were plated onto
glass bottom dishes (MatTek corp, Ashland, MA) coated
in 10% matrigel (BD Biosciences, San Jose, CA), and ei-
ther fixed immediately in 2% paraformaldehyde (PFA) or
cultured in plating medium for up to several days
in Dulbecco’s Minimum Essential Medium (DMEM,
Sigma, St. Louis, MO), 10% horse serum (HS, Gibco,
Carlsbad, CA), 0.5% chick embryo extract (CEE, US
Biologicals, Swampscott, MA) with streptomycin and
penicillin (GIBCO) at 37°C in 5% CO2. In order to de-
termine whether satellite cells had entered into the cell
cycle, myofibres were labelled with 10 μM Bromo-
deoxy Uridine (BrdU, Sigma) at the time of plating and
harvested after 24 hours in culture.
In order to generate primary myoblast cultures, myofi-
bers were washed from the plates after three days of cul-
ture and the medium was switched to growth medium(GM) containing DMEM, 10% HS, 20% fetal bovine serum
(FBS, Biowest, Miami, FL), 1% CEE, and 2.5 ng/mL basic
fibroblast growth factor (bFGF, Promega, Madison, WI).
Myoblasts were maintained in this medium for up to sev-
eral days. As cells reached 50-70% confluence, they were
passaged after pre-plating for 15 minutes on matrigel
coated dishes to remove fibroblasts, and plated on fresh
matrigel coated dishes. The purity of the myoblast cultures
was estimated by desmin staining to be > 95%. In order to
maintain the characteristics of the cells, all experiments
were carried out on myoblasts that had undergone 4 – 7
passages.
For experiments where cells were differentiated, cells
were plated on matrigel coated dishes and grown until
50% confluent. At that time, GM was exchanged for dif-
ferentiation medium (DM) containing DMEM, 2% HS,
10% FBS, 0.5% CEE, and antibiotics. Cells were differen-
tiated for 48 hours unless otherwise stated, harvested
and analysed. At the time of harvest, primary myoblasts
were fixed in 2% PFA for 15 minutes and washed several
times in phosphate buffered saline (PBS) and prepared
for immunostaining.
Adenoviral preparation
All adenoviral and corresponding control vectors were
obtained from MP Biomedicals (Montreal, QC). Full-
length mouse DUOXA1 was cloned into the BglII site of
the CMV5-IRES-EGFP AdenoVatorTM vector to create
CMV5-DUOXA1-IRES-EGFP and sequencing was per-
formed. The final adenoviral vector was created by
homologous recombination of the aforementioned vec-
tor with AdEasy, and virus was generated and amplified
in 293T cells. Viral purification was achieved using an
Adeno-X Virus Purification Kit (Clontech, Mountain
View, CA). CMV5-IRES-EGFP containing virus was used
as the corresponding control.
Viral infection
Primary myoblasts were plated and maintained in
growth medium until they reached 50-60% confluence.
At this time, cultures were infected with either CMV5-
DUOXA1-IRES-EGFP or CMV5-IRES-EGFP containing
viruses. Twenty-four hours after infection, GM was
replaced with DM, and cells were harvested after 48
hours of differentiation, unless otherwise stated. Samples
were harvested for mRNA, analyzed by microscopy or
prepared for H2O2 determination.
shRNA-mediated knockdown of DUOXA1 and
siRNA-mediated knockdown of DUOX1 or ASK1
Short hairpin RNA (shRNA) constructs targeting two
separate regions of the DUOXA1 gene and a control
construct targeting luciferase (3 μg) were used in knock-
down experiments. All DUOXA1 shRNA constructs and
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At the appropriate cell density, myoblasts (6 × 105 cells/
cuvette) were electroporated using an Amaxa Nucleofector
unit and NHDF solution (Lonza, Walkerville, MD).
Twenty-four hours after nucleofection, GM was re-
placed with DM, and cells were harvested after 48 hours
of differentiation. Samples were harvested for mRNA,
analyzed by microscopy or prepared for H2O2 deter-
mination. In order to determine whether knocking
down DUOX1 or ASK1 might rescue the phenotype
corresponding to DUOXA1 overexpression, siRNA
constructs targeting DUOX1, ASK1 or a scrambled
control were purchased from Santa Cruz (Santa Cruz,
CA). Small interfering RNA was introduced into prolif-
erative primary myoblasts using nucleofection de-
scribed above. Twenty four hours after nucleofection,
samples were infected with adenoviral vectors contain-
ing GFP-DUOXA1 or GFP alone. Differentiation was
initiated 24 hours after infection and samples were
harvested 24 or 48 hours later. Sequences used in the
preparation of siRNA and shRNA are presented in
Additional file 2: Table S1.
Immunostaining
Myofibres and myoblasts were permeabilized in 0.5%
and 0.2% triton-X 100, respectively. After blocking for
one hour in 1% bovine serum albumin (BSA), samples
were incubated overnight at 4°C in a solution containing
antibodies against MyoD (1:50), myogenin (1:50, Abcam,
Cambridge, MA), BrdU (1:1500), myosin heavy chain
(neat) (Developmental Studies Hybridoma Bank, Iowa),
desmin (1:200, Molecular Probes, Eugene, OR), and
DUOX1 (1:30, Santa Cruz, Santa Cruz, CA). For
DUOXA1 detection, an antibody was generated in our
lab against the C-terminal portion of the protein
(CFKEEHPKESD) and validated against a blocking
peptide [22]. Anti-DUOXA1 was used at a dilution of
1:300. Samples were washed and visualized with Alexa-
Fluor secondary antibodies diluted 1:1000 (Molecular
Probes). 4′6–diamidino-2-phenylindole (DAPI, Sigma)
was used as a nuclear marker. Confocal microscopy
was performed on a Zeiss LSM 510 META confocal
microscope (Carl Zeiss, Germany) using 20×, 40× or
63× objectives. Images were collected using Laser
Scanning Microscope (LSM) software and optimized
using PhotoImpression5 software.
Apoptosis assays
Apoptotic cells were identified using an Annexin V-Cy3
kit according to the manufacturer’s instructions (BioVision,
Mountain View, CA). Briefly, live cells were incubated in
binding buffer supplied with the kit, along with Annexin
V-Cy3 (1:100), propridium iodide (TOPRO-3, 1:1000) and
Hoechst 33342 (1:2000, Molecular Probes). Samples weremaintained in a heating block set to 37°C during analysis,
and cells undergoing early (Annexin V+/TOPRO-3-) or late
(Annexin V+/TOPRO-3+) apoptosis were compared with
the total number of cells (identified with Hoechst dye). In
overexpression experiments where GFP could be used as a
marker, only GFP+ cells were included in the analysis.
Hoechst dye, GFP, Annexin V-Cy3 and TOPRO-3 were
visualized using a Zeiss LSM 510 META confocal micro-
scope, with excitation lasers set to 405 nm, 488 nm,
543 nm and 633 nm, respectively.
RNA extraction, cDNA synthesis and quantitative reverse
transcription (qRT)-PCR
Total RNA was extracted from samples using TRIzol
reagent, according to the manufacturer’s instructions
(Invitrogen, Burlington, ON). First-strand cDNA was
generated from 100 to 300 ng RNA using the Quanti-
Tect Reverse Transcription kit (Qiagen, Toronto, ON),
which provides an initial step to eliminate genomic
DNA. The samples were diluted and 1/15 of this mixture
was quantified in subsequent PCR reactions using
PerfeCTa SYBR Green SuperMix (Quanta Biosciences,
Gaithersburg, MD). Samples were analyzed using the
Rotor-Gene Q (Qiagen, Toronto, ON) and the corre-
sponding software. Relative gene expression was calcu-
lated using the Ct method, and all samples were
normalized to glyceraldyhyde-3-phosphate dehydrogen-
ase (GAPDH). All averages ± S.D. are displayed as fold
changes relative to gene levels at d0 or to GFP control
cells, depending on the experiment. Primer pairs were
derived from the PrimerBank (http://pga.mgh.harvard.
edu/primerbank/), or from previous publications, and
are listed in Additional file 3: Table S2.
Measurement of H2O2 using Amplex Red
Hydrogen peroxide production was determined using an
Amplex Red kit (Molecular Probes), according to the
manufacturer’s instructions. In the presence of peroxid-
ase, Amplex Red reagent reacts with H2O2 (in 1:1 stoi-
chiometry) to produce a red fluorescent product called
resoruffin. The high extinction coefficient of resoruffin
allows for analysis either fluorometrically or spectro-
photometrically. Aliquots of medium were subsequently
removed and analyzed spectrophotometrically at a wave-
length of 560 nm. After H2O2 determination, samples
were washed thoroughly and corrected for cell number
using a CytoSelect colormetric assay kit (Cell Biolabs,
Inc., San Diego, CA). Dye from the stained cells was
extracted and quantified at OD 560 nm.
Statistical analysis
Where primary myoblasts were quantified by micros-
copy for a given antigen, cells from at least 10 random
fields were counted and scored. Primary myoblasts from
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mized and assembled into figures using Adobe Illustra-
tor. In order to determine the fusion index, the number
of structures containing 2 or more nuclei were analysed
from at least three separate mice. The fusion index was
calculated as:
ð of fused cells containing at least 2 nuclei=total
of cellsÞ x 100
In overexpression experiments (where GFP was available
as a marker), GFP+ cells were counted for quantification
and fusion was calculated as:
ð of fused GFPþcells containing at least 2 nuclei=
total of GFPþcellsÞ x 100
P < 0.05 was considered significantly different between
conditions, and was calculated using a Student’s t-test.
Additional files
Additional file 1: Figure S1. (A) In order to determine the specificity of
a lab-derived anti-DUOXA1 antibody, Western blotting was performed on
293 T cell samples transfected with either DUOXA1 or the corresponding
empty vector (CON). (B) Since DUOXA1 is known to be glycosylated [16],
we subjected 293 T cell lysates overexpressing DUOXA1 to N-glycosidase-F
for 2 hr at 37°C. Results demonstrate that deglycosylation results in the
DUOXA1 band migrating to its predicted weight of 37 kDa. (C-D)
Immunostaining was on primary mouse myoblasts. Samples were incubated
overnight with a rabbit anti-DUOXA1 antibody either in the absence (C), or
presence (D) of a blocking peptide (BP), and visualized with an Alexa 488
conjugated secondary antibody. Scale bars: 50 μm. Inset scale bars: 10 μm.
(E) Further support was derived from adenoviral infection of the immortalized
C2C12 myoblast cell line. Cells successfully infected with GFP-DUOXA1 show
bright green fluorescence (green) along with bright DUOXA1 staining (red)
indicating substantial overexpression of DUOXA1. GFP control cells do not
demonstrate elevated levels of DUOXA1. Scale bars: 20 μm.
Additional file 2: Table S1. Sequences used for siRNA and shRNA
construction.
Additional file 3: Table S2. Primers used for qRT-PCR.
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